Your session is about to expire
← Back to Search
Steroid Therapy for Head and Neck Cancer-Related Cranial Neuropathy
Study Summary
This trial is studying the side effects and best dose of steroid therapy in improving symptoms of late radiation-associated lower cranial neuropathy in oropharyngeal cancer survivors.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a throat blockage that hasn't been treated or didn't respond to treatment.You have a history of experiencing severe mental health issues like hallucinations or delusions.I have a diagnosed stomach or intestinal ulcer.I finished my radiotherapy at least 2 years ago and have been monitored since.I am an adult who has recovered from throat cancer.I have nerve damage in my lower skull not caused by cancer.I can come back for check-ups after steroid treatment.I can complete a symptom survey in one of the listed languages.I finished my cancer treatment over 2 years ago and have been monitoring since.I am an adult who has recovered from head and neck cancer without any signs of the disease.I have nerve damage in my lower skull from past radiation, not caused by cancer.My diabetes is not under control.My blood pressure is not higher than 160/90.You have been diagnosed with bipolar disorder in the past.
- Group 1: Supportive care (steroid therapy)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the total capacity of this trial regarding participants?
"That is accurate. According to clinicaltrials.gov, this trial was initially published on October 31st 2019 and revised most recently on November 10th 2022 with the aim of recruiting 25 participants from a single site."
Is enrollment in this trial ongoing at the present moment?
"The research project is recruiting according to clinicaltrials.gov, which has recorded its posting on October 31st 2019 and most recent update as November 10th 2022."
Are there any past inquiries into Methylprednisolone?
"At the moment, 403 studies associated with Methylprednisolone are being conducted. Of these trials, 113 have reached Phase 3 status. Most of these clinical research projects take place in Duarte California; however there is a total of 17147 sites across the globe running related experiments."
In what specific medical scenarios is Methylprednisolone regularly employed?
"Methylprednisolone can be prescribed to patients suffering from scalp structure issues, thyroiditis and ulcerative colitis."
What is the desired outcome of this experiment?
"This clinical trial is due to last for 3 weeks and will monitor the Change in MD Anderson Symptom Inventory - Head and Neck (MDASI-HN) top 5 mean. Secondary objectives include Changes in patient reported outcomes (PRO) on MD Anderson Dysphagia Inventory (MDADI), Performance Status Scale for Head and Neck (PSS-HN), or EuroQOL (EQ-5D). Specifically, this entails assessment of diet, eating, speech subscales of PSS-HN using an ordinal scale from 0 to 100; MDADI scores with a continuous scale from 20 to 100"
Share this study with friends
Copy Link
Messenger